Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
No BP has offered suitable financial incentives yet and lowball offers will be summarily dismissed.
major selling is occurring in the stock; the only question is who?
i will let someone figure that out
Websites lie too
It's right there on the company website.
We shall see when we get further data from our first 10.
In the release, PSTI said that six of the patients have completed the seven day follow up period. Nonetheless, in the 6 patients that have reached the follow up, there is a 100% survival rate as of today.
Importantly, four patients demonstrated improvement in respiratory parameters and three patients advanced stages of weaning from ventilators.
PSTI said that one of the patients has shown no change in respiratory parameters, but is still breathing with the assistance of a ventilator and remains relatively stable. Unfortunately, one patient has shown deterioration in respiratory parameters.
It’s also worth mentioning that two of the four patients with multi-organ failure prior to treatment showed clinical recovery in addition to respiratory improvement.
Not for an opinion but fraudulent claims most certainly can. The SEC of course does not have the resources to go after everyone. However a mass sweep of the scamming 50,000+ scam posters on this very board would be a good start.
https://www.law.cornell.edu/cfr/text/17/240.10b-5
You have been shown the FDA's 5 year exclusivity and 20 year patent life for new indications. You can no longer claim ignorance, you are flat out lying.
NONSENSE - GREAT-PROGRESS made this week
You must be desperate to try and push that crap.
Yep, that's why Pfizer with 5.5 billion shares should be on OTC.
supposedly?
The trial will be completed in September, and no results are yet available
I led you to water...
“Seriously sick coronavirus patients in New York state’s largest hospital system are being given massive doses of vitamin C
Since you must be new to biopharma I'll help you with your education.
https://www.fda.gov/drugs/development-approval-process-drugs/frequently-asked-questions-patents-and-exclusivity#howlongexclusivity
And don't forget 20 years patent protection for any new indication not patented already.
10 patients is not a $1 billion market cap in the real world
Long before you see one from your short position.
1. Almost a quarter billion in debt.
2. Issuances and convertible notes surrounded by non-material news
Over abundance of PR by shady firms such as WallStreetReporter.com, FinancialNewsMedia.com and a PR firm out of Florida (where all notorious stock frauds reside).
Those warrants were from an earlier offering.
The Company agreed to use commercially reasonable efforts to file a Registration Statement on Form S-3 with the SEC by April 30, 2020 registering a number of shares of Common Stock sufficient to convert the entire Outstanding Balance of the Note plus, if legally permissible, 1,666,668 shares of Common Stock from Investor’s February 12, 2020 warrant exercise plus 833,332 shares of Common Stock from Investor’s February 4, 2020 warrant exercise.
You can lead a short to water but you can't make him think.
You seem to have "misunderstood" the terms.
in any new offering by the Company of equity securities that have registration rights, are registered or become registered under the Securities Act of 1933
That preceded the loan, it's just common sense.
Have we made any public offering - no. So it is not dilutive unless we do so at less than $4.50, it's common sense.
Done deal
OTC can trade directly through the market maker.
Since the 100k doses was in the works maybe that was the minimum purchase.
"We believe we are going to inject the 75 patients within 10 days or so."
"We are going to be enrolling 350 patients but after the first 50 patients we will do interim analysis. I believe in 2 or 3 weeks we shall enroll all these patients"
He wouldn't release that information without authorization of the patient.
Italy and UK trials were previously mentioned in a video.
So many questions, so little due diligence.
Samsung is sending us 40,000 doses shortly, another 60,000 to follow and then the ramp up begins. Another useless question from you.
the Koreans (Samsung) have the formula and i believe that they could very well introduce their own version of hiv, cancer, cv19 drug
Do a comparative analysis of other small biopharmas since inception and your claim is shown to be spurious.
over a quarter billion $$$ in losses which is not good at all for any size company
1. Samsung is not the first line creditor.
2. You seem to not know that publicly traded companies can raise funds through offerings.
3. You are predicating your nonsense on the failure of approval in both COVID-19 and HIV.
Your continuing series of posts are so ludicrous that even a neophyte investor can see right through them. Make salient points and maybe someone will believe you.
do you think Samsung is probably licking their chops of a possible default?
false
IMMU - third-line treatment for late-stage, metastatic TNBC
Which means it would be used if leronlimab didn't work. Poor IMMU, left in the dust.
A single treatment able to effect ~5000-fold reduction in virus at 48h in cell culture.
If they're buying into what you're peddling than it's a valid warning.
OMG! In the Kiro7 interview no coffee cup is visible in Nader's office!!!! What does this portend!!!! Has he ran out of coffee!!!! Even worse, did he hide his cup in shame because it contained decaffeinated!!!! Will we ever know the answer to these momentous questions!!!!
Leronlimab - Disease List
An incomplete list of potential treatments targets for leronlimab.
Alzheimer's
Asthma
Atherosclerosis
Atopic Dermatitis
Cancer
Coeliac Disease
Chronic Fatigue Syndrome
COPD
COVID-19 (and other corona viruses)
Crohn's Disease
Colitis
Dermatomyositis
Diabetes (type 1)
Duchenne Muscular Dystrophy (possibly other muscular dystrophys also)
Emphysema
Fibromyalgia
Grave’s Disease
Guillain-Barre Syndrome
GVHD
Hashimoto’s Thyroiditis
Hepatitis (autoimmune)
HIV
Idiopathic Pulmonary Fibrosis
Inflammatory Bowel Disease
Influenza (severe)
Lambert-Eaton Syndrome
Lupus
Multiple Sclerosis
Myasthenia Gravis
Myocarditis
NASH
Neurofibromatosis
Parkinson's Disease
Pemphigus
Pneumonia
Polymyositis
Post-Myocardial Infarction Syndrome
Psoriasis
Rheumatic Fever
Rheumatoid Arthritis
Sarcoidosis
Scleroderma
Sickle Cell Disease (anti-inflammatory effect)
Sjogren’s Syndrome
Stroke
Tuberculosis
Vasculitis
CEO : Conrad Huss